These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 25448087)

  • 21. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses.
    Jonsson CB; Cao X; Lee J; Gabbard JD; Chu YK; Fitzpatrick EA; Julander J; Chung DH; Stabenow J; Golden JE
    Antiviral Res; 2019 Jul; 167():25-34. PubMed ID: 30970271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
    Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.
    Julander JG; Skirpstunas R; Siddharthan V; Shafer K; Hoopes JD; Smee DF; Morrey JD
    Antiviral Res; 2008 Jun; 78(3):230-41. PubMed ID: 18313150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein.
    Atasheva S; Krendelchtchikova V; Liopo A; Frolova E; Frolov I
    J Virol; 2010 Oct; 84(19):10004-15. PubMed ID: 20668087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
    Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
    Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.
    Sharma A; Knollmann-Ritschel B
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venezuelan equine encephalitis virus E1 protein interacts with PDIA6 and PDI inhibition reduces alphavirus production.
    Panny L; Akrhymuk I; Bracci N; Woodson C; Flor R; Elliott I; Zhou W; Narayanan A; Campbell C; Kehn-Hall K
    Antiviral Res; 2023 Apr; 212():105560. PubMed ID: 36822370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus.
    Bhomia M; Sharma A; Gayen M; Gupta P; Maheshwari RK
    Antiviral Res; 2013 Nov; 100(2):429-34. PubMed ID: 23988697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection.
    Lukaszewski RA; Brooks TJ
    J Virol; 2000 Jun; 74(11):5006-15. PubMed ID: 10799574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
    Atasheva S; Kim DY; Frolova EI; Frolov I
    J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection.
    Painter GR; Bowen RA; Bluemling GR; DeBergh J; Edpuganti V; Gruddanti PR; Guthrie DB; Hager M; Kuiper DL; Lockwood MA; Mitchell DG; Natchus MG; Sticher ZM; Kolykhalov AA
    Antiviral Res; 2019 Nov; 171():104597. PubMed ID: 31494195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication.
    Lundberg L; Pinkham C; Baer A; Amaya M; Narayanan A; Wagstaff KM; Jans DA; Kehn-Hall K
    Antiviral Res; 2013 Dec; 100(3):662-72. PubMed ID: 24161512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Venezuelan Equine Encephalitis Virus Using Small Interfering RNAs.
    Haikerwal A; Barrera MD; Bhalla N; Zhou W; Boghdeh N; Anderson C; Alem F; Narayanan A
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response.
    Ahmed A; Bakovic A; Risner K; Kortchak S; Der Torossian Torres M; de la Fuente-Nunez C; Lu T; Bhalla N; Narayanan A
    Sci Rep; 2020 Dec; 10(1):21491. PubMed ID: 33293592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
    Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
    J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine.
    Julander JG; Bowen RA; Rao JR; Day C; Shafer K; Smee DF; Morrey JD; Chu CK
    Antiviral Res; 2008 Dec; 80(3):309-15. PubMed ID: 18675850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.